MedTrace Logo

Intubation Conditions After RSI Using Rocuronium with Ephedrine Pretreatment

NCT05725031 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2024-10-15

No results posted yet for this study

Summary

This trial will study if ephedrine pretreatment before low doses of rocuronium (0.6 or 0.8 mg/kg) would provide similar intubating conditions as with the high dose of 1.2 mg/kg in patients undergoing RSII.

Conditions

  • Rapid Sequence Induction and Intubation

Interventions

DRUG

Ephedrine

70 μg/kg as pretreatment

DRUG

Rocuronium 0.6

0.6 mg/kg

DRUG

Rocuronium 0.8

0.8 mg/kg

DRUG

Rocuronium 1.2

1.2 mg/kg

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-02-01
Completion
2024-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05725031 on ClinicalTrials.gov